1. Home
  2. KOS vs MLAB Comparison

KOS vs MLAB Comparison

Compare KOS & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kosmos Energy Ltd. (DE)

KOS

Kosmos Energy Ltd. (DE)

N/A

Current Price

$2.27

Market Cap

1.1B

Sector

Energy

ML Signal

N/A

Logo Mesa Laboratories Inc.

MLAB

Mesa Laboratories Inc.

N/A

Current Price

$78.80

Market Cap

489.8M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
KOS
MLAB
Founded
2003
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Industrial Machinery/Components
Sector
Energy
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
489.8M
IPO Year
2011
1995

Fundamental Metrics

Financial Performance
Metric
KOS
MLAB
Price
$2.27
$78.80
Analyst Decision
Hold
Hold
Analyst Count
6
1
Target Price
$1.76
$94.00
AVG Volume (30 Days)
23.9M
97.1K
Earning Date
01-01-0001
05-04-2026
Dividend Yield
N/A
0.79%
EPS Growth
N/A
99.24
EPS
N/A
1.95
Revenue
$1,288,352,000.00
N/A
Revenue This Year
$16.95
$6.07
Revenue Next Year
$7.76
$5.41
P/E Ratio
N/A
$41.33
Revenue Growth
N/A
N/A
52 Week Low
$0.84
$59.63
52 Week High
$2.77
$130.12

Technical Indicators

Market Signals
Indicator
KOS
MLAB
Relative Strength Index (RSI) 56.40 36.17
Support Level $1.52 $77.23
Resistance Level $2.43 $81.62
Average True Range (ATR) 0.24 4.27
MACD -0.04 -2.06
Stochastic Oscillator 40.24 28.60

Price Performance

Historical Comparison
KOS
MLAB

About KOS Kosmos Energy Ltd. (DE)

Kosmos Energy Ltd is a deepwater exploration and production company focused on meeting the world's growing demand for energy. It has diversified oil and gas production from assets offshore Ghana, Equatorial Guinea, Mauritania, Senegal and the Gulf of America. The Company had operations in four geographic reporting segments: Ghana, Equatorial Guinea, Mauritania/Senegal and the Gulf of America. The majority of revenue is derived from the Ghana segment.

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Share on Social Networks: